Company:  SAREPTA THERAPEUTICS, INC ... (SRPT)
Form Type:  8-K
Filing Date:  8/7/2012 
CIK:  0000873303 
Address:  215 FIRST STREET
SUITE 7
 
City, State, Zip:  CAMBRIDGE, Massachusetts 02142 
Telephone:  857-242-3700 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$38.19  
Change: 
-0.72 (-1.85%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$1.44B
Description of Business
We are a biopharmaceutical company focused on the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. Applying our proprietary, highly-differentiated and innovative platform technologies, we are able to target a broad range of diseases and disorders through distinct RNA-based mechanisms of action. We are primarily focused on rapidly advancing the development of our potentially disease-modifying Duchenne muscular dystrophy (DMD) drug candidates, including our lead product candidate, eteplirsen. We are also focused on developing therapeutics for the treatment of infectious diseases, including our lead infectious disease program aimed at the development of a drug candidate for the Marburg hemorrhagic fever virus. By building our infectious disease programs which are primarily funded and supported by the U.S.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02 Results of Operations and Financial Condition.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 99.1
    BALANCE SHEET
BROKERAGE PARTNERS